Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Nectar Lifesciences Merger & Restructuring Worth ₹11.22 Cr

Nectar Lifesciences sold its non-core unit, Narbada Industries, including land leasehold rights and machinery, to Shree Balaji Cold Chain & Storage Services for ₹11.22 Crore.

Key figures
Value₹11.22 Cr
Source

BSE filing, NSE: NECLIFE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Nectar Lifesciences Ltd: key numbers

Share price
₹10.15
Market cap
₹227.6 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-292.9 Cr
P/E (TTM)
-0.9×Sector 41.3×
Promoter holding
51.84%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Nectar Lifesciences Ltd

All →

Other merger & restructuring announcements

All →